5Y News | QLT Biotherapeutics Raises Over 500 Million RMB in Series C Funding
Zhitai Biotech Closes Over 500 Million Yuan Series C Round to Accelerate Core Clinical Pipeline Development
五源资本
@5ycapital
535 articles
Articles
New Forces Keep Coming｜5Y News Monthly
The big news from last month.
5Y Capital Investor Notes: Agents Are a New Form of Life, and They're Hungry Today | 5Y View
The greatest investment opportunity isn't building a better Agent — it's becoming the water and air that the Agent world depends on to survive.
5Y Capital Investor Notes: Why Mingming Busy? The Truth Behind What's Misread as "Consumption Downgrade" | 5Y View
How does 5Y Capital identify "readaptation" signals in offline retail amid a challenging market environment?
5Y News｜Congratulations to Mingming Busy on its successful listing on the Hong Kong Stock Exchange!
Serving hundreds of millions of families with "value for quality."
5Y News｜Moonshot AI Releases and Open-Sources K2.5 Model, Bringing New Visual Understanding, Coding, and Agent Clustering Capabilities
The soul never thinks without a mental image.
5Y News｜"Natural Selection" Closes $30 Million Funding Round
Virtual companionship steps into the real world.
5Y News | Zai Ling Bio Completes Nearly RMB 600 Million Series C Financing
The funding will go toward global clinical development, pipeline expansion, and technology platform upgrades.
5Y News｜Humanify Raises Tens of Millions of RMB in Series A Funding to Build Human-Like Cognitive AI OS
Breaking the GUI OS paradigm, the AI-native era demands a fundamentally new "human-like cognition" operating system.
January, Emergence, and Prologue | 5Y News Monthly
The big news from last month.